https://www.asker.com/https://www.asker.com/about-us/https://www.asker.com/about-us/our-identity/https://www.asker.com/about-us/organisation/https://www.asker.com/about-us/askers-twin-engine/https://www.asker.com/about-us/board-of-directors/https://www.asker.com/about-us/management-team/https://www.asker.com/about-us/corporate-governance/https://www.asker.com/about-us/corporate-governance/articles-of-association/https://www.asker.com/about-us/corporate-governance/corporate-governance-report/https://www.asker.com/about-us/corporate-governance/general-meeting/https://www.asker.com/about-us/corporate-governance/general-meeting/egm-2025/https://www.asker.com/about-us/corporate-governance/general-meeting/agm-2026/https://www.asker.com/about-us/corporate-governance/general-meeting/egm-2025-2/https://www.asker.com/about-us/corporate-governance/nomination-committee/https://www.asker.com/about-us/corporate-governance/board-committees/https://www.asker.com/about-us/corporate-governance/internal-control/https://www.asker.com/about-us/corporate-governance/remuneration/https://www.asker.com/about-us/corporate-governance/auditors/https://www.asker.com/about-us/corporate-governance/asker-management-standard/https://www.asker.com/about-us/history/https://www.asker.com/about-us/career/https://www.asker.com/about-us/asker-business-school/https://www.asker.com/about-us/whistleblowing/https://www.asker.com/our-companies/https://www.asker.com/cookies/https://www.asker.com/entrepreneurs/https://www.asker.com/entrepreneurs/what-we-are-looking-for/https://www.asker.com/entrepreneurs/being-part-of-asker/https://www.asker.com/entrepreneurs/acquisition-process/https://www.asker.com/entrepreneurs/meet-our-entrepreneurs/https://www.asker.com/entrepreneurs/meet-our-entrepreneurs/vegro/https://www.asker.com/entrepreneurs/meet-our-entrepreneurs/michael-schlapp/https://www.asker.com/entrepreneurs/meet-our-entrepreneurs/cornel-kagi/https://www.asker.com/entrepreneurs/meet-our-entrepreneurs/pieter-jan-jongeling/https://www.asker.com/entrepreneurs/contact/https://www.asker.com/page-not-found/https://www.asker.com/sustainability/https://www.asker.com/sustainability/esg-focus-areas/https://www.asker.com/sustainability/esg-focus-areas/healthy-communities/https://www.asker.com/sustainability/esg-focus-areas/healthy-planet/https://www.asker.com/sustainability/esg-focus-areas/healthy-people/https://www.asker.com/sustainability/sustainability-reporting/https://www.asker.com/sustainability/sustainability-reporting/sustainability-reports/https://www.asker.com/sustainability/sustainability-reporting/targets-and-achievements/https://www.asker.com/sustainability/sustainability-reporting/science-based-targets/https://www.asker.com/sustainability/sustainability-reporting/certificates/https://www.asker.com/sustainability/sustainability-reporting/tcfd/https://www.asker.com/sustainability/how-we-contribute/https://www.asker.com/sustainability/how-we-contribute/case-supporting-emergency-care/https://www.asker.com/sustainability/how-we-contribute/case-innovative-iv-therapy/https://www.asker.com/sustainability/how-we-contribute/case-new-wound-care-solution/https://www.asker.com/sustainability/how-we-contribute/case-digital-solutions/https://www.asker.com/sustainability/how-we-contribute/case-own-audit-office/https://www.asker.com/sustainability/how-we-contribute/case-collaboration-throughout-the-value-chain/https://www.asker.com/sustainability/how-we-contribute/case-sustainable-procurement/https://www.asker.com/sustainability/how-we-contribute/case-supporting-migrant-workers/https://www.asker.com/sustainability/how-we-contribute/case-energy-efficiency-project/https://www.asker.com/sustainability/standards-and-policies/https://www.asker.com/sustainability/standards-and-policies/living-wage/https://www.asker.com/sustainability/community-engagement/https://www.asker.com/data-privacy-process/https://www.asker.com/investors-and-media/https://www.asker.com/investors-and-media/press-releases-and-news/https://www.asker.com/investors-and-media/press-releases-and-news/2026/changes-in-askers-group-management-team/https://www.asker.com/investors-and-media/press-releases-and-news/2026/invitation-to-asker-healthcare-groups-year-end-report-2025-webcast/https://www.asker.com/investors-and-media/press-releases-and-news/2026/acquisition-of-ghc-and-mpf/https://www.asker.com/investors-and-media/press-releases-and-news/2026/notice-of-annual-general-meeting-in-asker-healthcare-group-ab-publ/https://www.asker.com/investors-and-media/press-releases-and-news/2026/acquisition-of-rms-medical-devices/https://www.asker.com/investors-and-media/press-releases-and-news/2026/change-in-the-number-of-shares-and-votes-in-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2026/issuance-repurchase-and-reclassification-of-class-c-shares-under-incentive-program-in-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2026/nomination-committees-proposal-for-board-of-directors-of-asker-ahead-of-the-2026-annual-general-meeting/https://www.asker.com/investors-and-media/press-releases-and-news/2026/year-end-report-1-january31-december-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-van-heek-medical/https://www.asker.com/investors-and-media/press-releases-and-news/2025/bulletin-from-extraordinary-general-meeting-in-asker-healthcare-group-ab-publ-on-9-december-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-cardio-depot/https://www.asker.com/investors-and-media/press-releases-and-news/2025/invitation-to-asker-healthcare-groups-q3-2025-webcast/https://www.asker.com/investors-and-media/press-releases-and-news/2025/notice-of-extraordinary-general-meeting-in-asker-healthcare-group-ab-publ-2025-11-14/https://www.asker.com/investors-and-media/press-releases-and-news/2025/interogo-holding-announces-intragroup-transfer-of-its-shares-in-asker-from-nalka-invest-to-its-long-term-equity-strategy-and-nomination-committee-proposes-new-board-member/https://www.asker.com/investors-and-media/press-releases-and-news/2025/interim-report-1-january30-september-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-innomedicus/https://www.asker.com/investors-and-media/press-releases-and-news/2025/change-of-nomination-committee-members-in-asker-healthcare-group-ahead-of-the-2026-annual-general-meeting/https://www.asker.com/investors-and-media/press-releases-and-news/2025/asker-healthcare-groups-nomination-committee-for-the-annual-general-meeting-2026/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-novus-med/https://www.asker.com/investors-and-media/press-releases-and-news/2025/asker-announces-an-increase-in-the-number-of-shares-and-votes/https://www.asker.com/investors-and-media/press-releases-and-news/2025/invitation-to-askers-q1-2025-webcast/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-ms-labors/https://www.asker.com/investors-and-media/press-releases-and-news/2025/interim-report-1-january-31-march-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-itak/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-kirstine-hardam/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-hospital-services-limited/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-mayumana-healthcare/https://www.asker.com/investors-and-media/press-releases-and-news/2025/asker-publishes-annual-and-sustainability-report-2024/https://www.asker.com/investors-and-media/press-releases-and-news/2025/bulletin-from-extraordinary-general-meeting-in-asker-healthcare-group-ab-publ-on-27-august-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-scan-modul/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-oudshoorn/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-hnc/https://www.asker.com/investors-and-media/press-releases-and-news/2025/invitation-to-askers-q2-2025-webcast/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-dartin/https://www.asker.com/investors-and-media/press-releases-and-news/2025/acquisition-of-finmed-group-first-acquisition-in-france/https://www.asker.com/investors-and-media/press-releases-and-news/2025/notice-of-extraordinary-general-meeting-in-asker-healthcare-group-ab-publ/https://www.asker.com/investors-and-media/press-releases-and-news/2025/interim-report-1-january-30-june-2025/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-aspironix/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-wolturnus/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-funktionsverket/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-meetb/https://www.asker.com/investors-and-media/press-releases-and-news/2024/hanna-merikanto-appointed-new-country-manager-for-finland-and-four-business-areas-become-three/https://www.asker.com/investors-and-media/press-releases-and-news/2024/askers-2023-annual-and-sustainability-report/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-praximedico/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-hugo-technology/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-kvinto-as/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-operations-from-summed-finland-oy/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-opitek/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquisition-of-hauser-medizintechnik/https://www.asker.com/investors-and-media/press-releases-and-news/2024/acquistion-of-exclusive-distribution-rights-in-switzerland/https://www.asker.com/investors-and-media/press-releases-and-news/2024/asker-awarded-renewed-platinum-rating-from-ecovadis/https://www.asker.com/investors-and-media/press-releases-and-news/2023/asker-in-top-tier-of-sustainable-companies-according-to-ecovadis/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-mc-europe/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-vegro/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-eumedics-medizintechnik/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-crs-medical/https://www.asker.com/investors-and-media/press-releases-and-news/2023/askers-climate-targets-approved-by-sbti/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-unimeda/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-vi-tri-medical/https://www.asker.com/investors-and-media/press-releases-and-news/2023/strengthened-offering-within-medical-equipment/https://www.asker.com/investors-and-media/press-releases-and-news/2023/askers-2022-annual-and-sustainability-report/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-instrumenta/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-optiikka-juurinen/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-andre-surgical/https://www.asker.com/investors-and-media/press-releases-and-news/2023/asker-supports-health-initiative-in-india/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-genimedical/https://www.asker.com/investors-and-media/press-releases-and-news/2023/asker-donates-medical-supplies-to-earthquake-victims-in-turkey-and-syria/https://www.asker.com/investors-and-media/press-releases-and-news/2023/acquisition-of-dispo-medical/https://www.asker.com/investors-and-media/press-releases-and-news/2023/asker-engage-in-efforts-to-keep-plastic-waste-from-the-oceans/https://www.asker.com/investors-and-media/press-releases-and-news/2022/asker-awarded-a-gold-rating-by-ecovadis/https://www.asker.com/investors-and-media/press-releases-and-news/2022/taking-greater-responsibility-to-reduce-the-climate-impact-of-healthcare/https://www.asker.com/investors-and-media/press-releases-and-news/2022/first-acquisition-in-austria-heintel-gruppe/https://www.asker.com/investors-and-media/press-releases-and-news/2022/acquisition-of-aichele-medico/https://www.asker.com/investors-and-media/press-releases-and-news/2022/acquisition-of-adcuris/https://www.asker.com/investors-and-media/press-releases-and-news/2022/sustainability-report-2021-published/https://www.asker.com/investors-and-media/press-releases-and-news/2022/asker-awarded-silver-for-its-sustainability-work/https://www.asker.com/investors-and-media/press-releases-and-news/2022/acquisition-of-deforce-medical/https://www.asker.com/investors-and-media/press-releases-and-news/2022/strengthening-the-offer-within-surgical-instruments/https://www.asker.com/investors-and-media/press-releases-and-news/2022/acquisition-of-the-swiss-medical-device-provider-gribi-ag-belp/https://www.asker.com/investors-and-media/press-releases-and-news/2022/acquisition-of-the-danish-mobility-equipment-company-mobilex/https://www.asker.com/investors-and-media/press-releases-and-news/2022/support-to-families-and-critical-care-in-ukraine/https://www.asker.com/investors-and-media/press-releases-and-news/2022/strengthening-the-asker-healthcare-group-the-acquisition-of-medireva-completed/https://www.asker.com/investors-and-media/press-releases-and-news/2022/new-head-of-ma-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/strengthening-group-management-team-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/enters-an-agreement-to-acquire-medireva-with-eur-150-mn-in-revenue-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/stronger-in-benelux-via-acquisition-of-stopler-with-eur-45-mn-in-revenue-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/new-head-of-communication-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-swemed-an-online-based-distributor-of-healthcare-equipment-and-supplies-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-zibocare-a-danish-distributor-of-medical-devices-and-solutions-within-pressure-relieving-and-sensory-stimulating-aids-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-scandivet-a-distributor-of-equipment-and-consumables-for-veterinary-care-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-pharma-dynamic-a-dutch-trading-specialist-for-medical-products-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-gymo-as-a-norwegian-supplier-of-medical-equipment-and-disposables-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-fysiosupplies-a-dutch-total-supplier-for-physiotherapy-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-iogen-a-finnish-eye-surgery-products-distributor-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2021/acquires-a-majority-share-in-the-two-german-companies-diashop-and-evivamed-asker-healthcare-group/https://www.asker.com/investors-and-media/press-releases-and-news/2020/acquires-a-majority-share-of-the-swiss-distributor-smedico-asker-healthcare-group/https://www.asker.com/investors-and-media/financial-reports-and-presentations/interim-report-1-january30-september-2025/https://www.asker.com/investors-and-media/financial-reports-and-presentations/interim-report-1-january-31-march-2025/https://www.asker.com/investors-and-media/financial-reports-and-presentations/interim-report-1-january-30-june-2025/https://www.asker.com/investors-and-media/financial-reports-and-presentations/asker-publishes-annual-and-sustainability-report-2024/https://www.asker.com/investors-and-media/financial-reports-and-presentations/year-end-report-1-january31-december-2025/https://www.asker.com/investors-and-media/financial-reports-and-presentations/askers-2023-annual-and-sustainability-report/https://www.asker.com/investors-and-media/financial-reports-and-presentations/askers-2022-annual-and-sustainability-report/https://www.asker.com/investors-and-media/financial-calendar/https://www.asker.com/investors-and-media/financial-targets/https://www.asker.com/investors-and-media/asker-as-an-investment/https://www.asker.com/investors-and-media/the-share/https://www.asker.com/investors-and-media/the-share/shareholders/https://www.asker.com/investors-and-media/the-share/analysts/https://www.asker.com/investors-and-media/the-share/insider-trading/https://www.asker.com/investors-and-media/the-share/dividend-policy/https://www.asker.com/investors-and-media/risk-and-risk-management/https://www.asker.com/investors-and-media/image-bank/https://www.asker.com/investors-and-media/ir-and-media-contact/https://www.asker.com/investors-and-media/subscribe/https://www.asker.com/contact-us/https://www.asker.com/sv/https://www.asker.com/sv/om-oss/https://www.asker.com/sv/om-oss/var-identitet/https://www.asker.com/sv/om-oss/organisation/https://www.asker.com/sv/om-oss/askers-twin-engine/https://www.asker.com/sv/om-oss/styrelse/https://www.asker.com/sv/om-oss/ledningsgrupp/https://www.asker.com/sv/om-oss/bolagsstyrning/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsordning/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsstyrningsrapport/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsstammor/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsstammor/egm-2025/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsstammor/arsstamma-2026/https://www.asker.com/sv/om-oss/bolagsstyrning/bolagsstammor/egm-2025-2/https://www.asker.com/sv/om-oss/bolagsstyrning/valberedning/https://www.asker.com/sv/om-oss/bolagsstyrning/styrelseutskott/https://www.asker.com/sv/om-oss/bolagsstyrning/intern-kontroll/https://www.asker.com/sv/om-oss/bolagsstyrning/ersattningar/https://www.asker.com/sv/om-oss/bolagsstyrning/revisorer/https://www.asker.com/sv/om-oss/bolagsstyrning/asker-management-standard/https://www.asker.com/sv/om-oss/historia/https://www.asker.com/sv/om-oss/karriar/https://www.asker.com/sv/om-oss/asker-business-school/https://www.asker.com/sv/om-oss/visselblasning/https://www.asker.com/sv/vara-foretag/https://www.asker.com/sv/cookies/https://www.asker.com/sv/entreprenorer/https://www.asker.com/sv/entreprenorer/vad-vi-letar-efter/https://www.asker.com/sv/entreprenorer/vara-en-del-av-asker/https://www.asker.com/sv/entreprenorer/forvarvsprocessen/https://www.asker.com/sv/entreprenorer/mot-vara-entreprenorer/https://www.asker.com/sv/entreprenorer/mot-vara-entreprenorer/vegro/https://www.asker.com/sv/entreprenorer/mot-vara-entreprenorer/michael-schlapp/https://www.asker.com/sv/entreprenorer/mot-vara-entreprenorer/cornel-kagi/https://www.asker.com/sv/entreprenorer/mot-vara-entreprenorer/pieter-jan-jongeling/https://www.asker.com/sv/entreprenorer/kontakt/https://www.asker.com/sv/sidan-kunde-inte-hittas/https://www.asker.com/sv/hallbarhet/https://www.asker.com/sv/hallbarhet/fokusomraden-inom-hallbarhet/https://www.asker.com/sv/hallbarhet/fokusomraden-inom-hallbarhet/healthy-communities/https://www.asker.com/sv/hallbarhet/fokusomraden-inom-hallbarhet/healthy-planet/https://www.asker.com/sv/hallbarhet/fokusomraden-inom-hallbarhet/healthy-people/https://www.asker.com/sv/hallbarhet/hallbarhetsrapportering/https://www.asker.com/sv/hallbarhet/hallbarhetsrapportering/hallbarhetsrapporter/https://www.asker.com/sv/hallbarhet/hallbarhetsrapportering/mal-och-utfall/https://www.asker.com/sv/hallbarhet/hallbarhetsrapportering/vetenskapsbaserade-mal/https://www.asker.com/sv/hallbarhet/hallbarhetsrapportering/tcfd/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-stodjer-akutvardspersonal/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-innovativ-iv-terapi/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-innovativ-sarvardslosning/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-digitala-losningar/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-egen-granskningsavdelning/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-samarbete-genom-vardekedjan/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-hallbar-upphandling/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-stod-till-migrantarbetstagare/https://www.asker.com/sv/hallbarhet/hur-vi-bidrar/case-energieffektivitetsprojekt/https://www.asker.com/sv/hallbarhet/standarder-och-policyer/https://www.asker.com/sv/hallbarhet/standarder-och-policyer/levnadslon/https://www.asker.com/sv/hallbarhet/samhallsengagemang/https://www.asker.com/sv/data-privacy-process/https://www.asker.com/sv/investerare-och-media/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/bokslutskommunike-1-januari31-december-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/forandringar-i-askers-koncernledning/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/inbjudan-till-asker-healthcare-groups-webcast-for-bokslutskommuniken-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/forvarv-av-ghc-och-mpf/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/andring-av-antalet-aktier-och-roster-i-asker-healthcare-group/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/kallelse-till-arsstamma-i-asker-healthcare-group-ab-publ/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/forvarv-av-rms-medical-devices/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/emission-aterkop-och-omvandling-av-c-aktier-inom-ramen-for-incitamentsprogram-i-asker-healthcare-group/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2026/valberedningens-forslag-till-styrelse-i-asker-infor-arsstamman-2026/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-cardio-depot/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-van-heek-medical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/kommunike-fran-extra-bolagsstamma-i-asker-healthcare-group-ab-publ-den-9-december-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/kallelse-till-extra-bolagsstamma-i-asker-healthcare-group-ab-publ-2025-11-14/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/interogo-holding-genomfor-en-intern-koncernoverlatelse-av-sina-aktier-i-asker-fran-nalka-invest-till-sin-langsiktiga-aktiestrategi-och-valberedningen-foreslar-ny-styrelseledamot/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/delarsrapport-1-januari30-september-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-innomedicus/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/valberedning-for-asker-healthcare-group-infor-arsstamman-2026/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/andring-av-valberedningens-ledamoter-i-asker-healthcare-group-infor-arsstamman-2026/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-novus-med/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/inbjudan-till-asker-healthcare-groups-webcast-for-tredje-kvartalet-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/asker-meddelar-okning-av-antalet-aktier-och-roster/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/inbjudan-till-askers-webcast-for-forsta-kvartalet-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-ms-labors/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/delarsrapport-1-januari31-mars-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-itak/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-kirstine-hardam/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-hospital-services-limited/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-mayumana-healthcare/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/asker-publicerar-ars-och-hallbarhetsredovisning-for-2024/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-oudshoorn/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/kommunike-fran-extra-bolagsstamma-i-asker-healthcare-group-ab-publ-den-27-augusti-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-hnc/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-scan-modul/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/inbjudan-till-askers-webcast-for-andra-kvartalet-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-dartin/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/forvarv-av-finmed-group-forsta-forvarvet-i-frankrike/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/delarsrapport-1-januari30-juni-2025/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2025/kallelse-till-extra-bolagsstamma-i-asker-healthcare-group-ab-publ/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-aspironix/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-wolturnus/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-funktionsverket/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-meetb/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/hanna-merikanto-ny-landschef-for-finland-och-fyra-affarsomraden-blir-tre/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/askers-ars-och-hallbarhetsredovisning-2023/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-praximedico/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-hugo-technology/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-kvinto-as/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-verksamheten-i-summed-finland-oy/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-opitek/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-hauser-medizintechnik/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/forvarv-av-distributionsrattigheter-i-schweiz/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2024/asker-tilldelas-fornyat-platinum-betyg-av-ecovadis/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/asker-i-toppskiktet-av-hallbara-foretag-enligt-ecovadis/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-mc-europe/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-vegro/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-eumedics-medizintechnik/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-crs-medical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/askers-klimatmal-godkanda-av-sbti/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-unimeda/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-vi-tri-medical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/starkt-erbjudande-inom-medicinteknisk-utrustning/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/askers-ars-och-hallbarhetsredovisning-2022/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-instrumenta/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-optiikka-juurinen/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-andre-surgical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/asker-stodjer-initiativ-for-god-halsa-i-indien/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-genimedical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/asker-donerar-medicinskt-forbrukningsmaterial-till-jordbavningsoffer-i-turkiet-och-syrien/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/forvarv-av-dispo-medical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2023/asker-stodjer-initiativ-for-att-minska-plastavfall-i-haven/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/asker-har-tilldelats-guld-av-ecovadis/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/tar-ett-storre-ansvar-for-att-minska-klimatpaverkan-i-varden/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forsta-forvarvet-i-osterrike-heintel-gruppe/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forvarv-av-aichele-medico/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forvarv-av-adcuris/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/asker-publicerar-hallbarhetsrapport-for-2021/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/asker-har-tilldelats-silver-av-ecovadis-for-sitt-hallbarhetsarbete/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forvarv-av-deforce-medical/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/starkt-erbjudande-inom-kirurgiska-instrument/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forvarv-av-den-schweiziska-medicinteknikleverantoren-gribi-ag-belp/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/forvarv-av-det-danska-hjalpmedelsforetaget-mobilex/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/hjalp-till-familjer-och-akutsjukvard-i-ukraina/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/asker-healthcare-group-starkt-forvarvet-av-medireva-slutfort/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2022/ola-nordh-utsedd-till-ny-ma-chef/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forstarkning-av-koncernledningsgruppen-asker-healthcare-group/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/ingar-avtal-om-att-forvarva-medireva-med-150-miljoner-euro-i-omsattning-asker-healthcare-group/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/starkare-i-benelux-genom-forvarv-av-stopler-med-45-mn-euro-i-omsattning/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/ny-kommunikationschef-asker-healthcare-group/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-swemed-en-onlinebaserad-distributor-av-sjukvardsutrustning-och-tillbehor/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-zibocare-en-dansk-distributor-av-medicintekniska-produkter-och-losningar-inom-tryckavlastande-och-sensoriskt-stimulerande-hjalpmedel/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-scandivet-en-distributor-av-utrustning-och-forbrukningsmaterial-for-veterinarvard/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-pharma-dynamic-en-hollandsk-handelsspecialist-for-medicinska-produkter/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-gymo-as-en-norsk-leverantor-av-medicinsk-utrustning-och-engangsartiklar/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-fysiosupplies-en-hollandsk-totalleverantor-inom-fysioterapi/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-iogen-en-finsk-distributor-av-produkter-for-ogonkirurgi/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2021/forvarv-av-en-majoritetsandel-i-de-tva-tyska-bolagen-diashop-och-evivamed/https://www.asker.com/sv/investerare-och-media/pressmeddelanden-och-nyheter/2020/forvarv-av-en-majoritetsandel-i-den-schweiziska-distributoren-smedico/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/bokslutskommunike-1-januari31-december-2025/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/asker-publicerar-ars-och-hallbarhetsredovisning-for-2024/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/delarsrapport-1-januari30-september-2025/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/delarsrapport-1-januari31-mars-2025/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/delarsrapport-1-januari30-juni-2025/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/askers-ars-och-hallbarhetsredovisning-2023/https://www.asker.com/sv/investerare-och-media/finansiella-rapporter-och-presentationer/askers-ars-och-hallbarhetsredovisning-2022/https://www.asker.com/sv/investerare-och-media/finansiell-kalender/https://www.asker.com/sv/investerare-och-media/finansiella-mal/https://www.asker.com/sv/investerare-och-media/asker-som-investering/https://www.asker.com/sv/investerare-och-media/aktien/https://www.asker.com/sv/investerare-och-media/aktien/aktieagare/https://www.asker.com/sv/investerare-och-media/aktien/analytiker/https://www.asker.com/sv/investerare-och-media/aktien/insynshandel/https://www.asker.com/sv/investerare-och-media/aktien/utdelningspolicy/https://www.asker.com/sv/investerare-och-media/risk-och-riskhantering/https://www.asker.com/sv/investerare-och-media/bildbank/https://www.asker.com/sv/investerare-och-media/ir-och-mediakontakter/https://www.asker.com/sv/investerare-och-media/prenumerera/https://www.asker.com/sv/kontakta-oss/